Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses

British Medical Journal

Volumn 321, Issue 7255, 2000, Pages 199-204

  Danesh, John ^a   Whincup, Peter ^b   Walker, Mary ^c   Lennon, Lucy ^c   Thomson, Andrew ^c   Appleby, Paul ^d   Gallimore, J Ruth ^c   Pepys, Mark B ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HOMOCYSTEINE; IMMUNOGLOBULIN G; SERUM AMYLOID A;

ADULT; AGE; AMINO ACID BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHLAMYDOPHILA PNEUMONIAE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH CERTIFICATE; GENERAL PRACTICE; HEART INFARCTION; HELICOBACTER PYLORI; HUMAN; INFECTION; INFLAMMATION; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SMOKING; SOCIAL STATUS;

EID: 0034702485     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.321.7255.199     Document Type: Article

References (34)

1. 1 Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive and related proteins (pentaxins) and serum amyloid A protein. Adv Immun 1983;34:141-212.
2. 2 Danesh J, Collins R, Appleby P, Peto R. Fibrinogen. C-reactive protein, albumin or white cell count: meta-analyses of prospective studies of coronary heart disease. JAMA 1998;279:1477-82.
3. 3 Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999;100:230-5.
4. 4 Wilkins J, Gallimore JR, Moore EG, Pepys MB. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin Chem 1998;44:1358-61.
5. 5 Wilkins J, Gallimore JR, Tennent GA, Hawkins PN, Limburg PC, van Rijswijk MH, et al. Rapid automated enzyme immunoassay of serum amyloid A. Clin Chem 1994;40:1284-90.
6. 6 Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-21.
7. 7 Lagrand WK, Visser CA, Hermens W, Niessen WH, Verheugt FW, Wolbink GJ, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999;100:96-102.
8. 8 Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
9. 9 Danesh J. Smouldering arteries? Low-grade inflammation and coronary heart disease. JAMA 1999;282:2169-71.
10. 10 Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-55.
11. 11 Shaper AG, Pocock SJ, Walker M, Cohen NM, Wale CJ, Thomson AG. British regional heart study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ 1981;283:179-86.
12. 12 Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989;ii:1434-6.
13. 13 Phillips AN, Neaton JD, Cook DG, Grimm RH, Shaper AG. Leukocyte count and risk of coronary heart disease. Am J Epidemiol 1992;136:59-70.
14. 14 Poole S, Walker D, Gaines Das RE, Gallimore JR, Pepys MB. The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study. J Immunol Methods 1998;214:1-10.
15. 15 Wong Y-K, Sueur JM, Fall CHD, Orfila J, Ward ME. The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring antibodies against Chlamydia pneumoniae. J Clin Pathol 1999;2:99-103.
16. 16 Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999;150: 341-53.
17. 17 Lowe GDO, Rumely A, Sweetnam PM, Yarnell JWG. Fibrin D-dimer. C-reactive protein and risk of ischaemic heart disease: the Speedwell study. Blood Coagul Fibrin 1999;10 (suppl 1):S92-3.
18. 18 Agewall S, Wikstrand J, Fagerberg B. Prothrombin fragment 1 + 2 is a risk factor for myocardial infarction in treated hypertensive men. J Hypertension 1998;16:537-41.
19. 19 Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3.
20. 20 Witherell HL, Smith KL, Les C, Freidman GD, Orentreich N, Vogelman JH. Helicobacter pylori infection, C-reactive protein, and risk for myocardial infarction: a prospective study. Gastroenterology 1999;116:A355.
21. 21 Roivainen M, Viik-Kajarnder M, Palosun T, Sacks F Braunwald E. Infections, inflammation, and the risk of coronary heart disease. Circulation 2000;101:257.
22. 22 Ridker PM, Rifai N, Pfeffer MA, Toivanen P, Leinonen M, Saikku P, et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998;98:839-44.
23. 23 Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New Engl J Med 1997;336:973-9.
24. 24 Koenig W, Sund M, Frohlicb M, Fischer HG, Lowel H, Doring A, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA-Augsburg cohort study, 1984-1992. Circulation 1999;99:237-42.
25. 25 Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-47.
26. 26 Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the cardiovascular health study and the rural health promotion project. Arterioscler Thromb Vasc Biol 1997;17:1121-7.
27. 27 Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 1997;96:4204-10.
28. 28 Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997;349:462-6.
29. 29 Zhang YX, Cliff WJ, Schoefl GI, Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 1999;145:375-9.
30. 30 Cermak JC, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-20.
31. 31 de Beer FC, Soutar AK, Baltz ML, Trayner I, Feinstein A, Pepys MB. Low density and very loss density lipoproteins are selectively bound by aggregated C-reactive protein. J Exp Med 1982;156:230-42.
32. 32 Bhakdi S, Torzewski M, Klouche M, Hemmes M. Complement activation and atherogenesis. Binding of CRP to degraded, nonoxidised LDL enhances complement activation. Arterioscler Thromb Vasc Biol 1999;19:2348-54.
33. 33 Cushman M, Legault C, Barrett-Connor EL, Stefanick ML, Kessler C, Judd HL, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the postmenopausal estrogen/ progestin interventions (PEPI) study. Circulation 1999;100:717-22.
34. 34 Ridker PM, Hennekens CH, Buring JE, Rifai N. C reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl Med 2000;342:836-43. (Accepted 22 February 2000)